Armstrong Pharmaceuticals: Asthma Relief Soon to Revert to Rx-only Indication
3/17/2011 7:15:57 AM
SILVER SPRING, Md., March 16, 2011 /PRNewswire-USNewswire/ -- The only over-the-counter asthma inhaler sold in the United States will no longer be available next year as part of an international agreement to stop the use of substances that damage the environment.
Learn more about why Primatene Mist is being discontinued and what asthma sufferers can do at
Sign up for e-mail notices of new FDA Consumer Updates at
View the FDA Consumer Update RSS feed at http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml
FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to email@example.com.
Media Inquiries: Karen Riley at 301-796-4674; firstname.lastname@example.org
SOURCE U.S. Food and Drug Administration